FLT3 and acute myeloid leukemia: These studiesintersect in cancer research, particularly in understanding the molecular mechanisms underlying AML, developing targeted therapiesderived from PLX3398 against specific molecular targets, such as FLT3 mutations, and utilizing computational approaches(In silico) to accelerate drug discovery and optimize treatment strategies.